alpha-MSH analogue comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-01-26. Where a claim depends on a specific study, the study is described rather than over-claimed.
Melanotan II holds no marketing authorisation from the Food and Drug Administration, the European Medicines Agency, the UK Medicines and Healthcare products Regulatory Agency or Australia's Therapeutic Goods Administration. Products sold under that name are treated as unapproved new drugs, and their sale or import is prohibited in several jurisdictions. Other countries classify the peptide as a prescription-only medicine or place it among controlled substances, so the legal position changes with the destination market. No pharmacopoeial monograph supplies an official specification, because the material is not a licensed pharmaceutical. Consequently, products offered online are not manufactured to a shared public standard.
The peer-reviewed record is dominated by small early-phase studies, case reports and pharmacovigilance summaries rather than large randomised trials. Papers typically examine tanning response, receptor selectivity or patterns of reported adverse events. Many note that participants obtained the peptide outside a clinical setting, which limits verification of composition and administered amount. Reported events vary widely, and causality is frequently unclear because the identity and purity of self-sourced material are unknown. Open questions include whether repeated melanocortin receptor stimulation produces cumulative effects, and how often label claims match actual content.
Identification in laboratories relies on reversed-phase liquid chromatography coupled with tandem mass spectrometry, with product-ion spectra compared against a certified reference standard. High-resolution mass spectrometry supplies accurate mass confirmation, and peptide mapping after enzymatic digestion separates melanotan II from closely related analogues. Quantitation of seized material is complicated by unknown counter-ions and residual trifluoroacetate left from purification. Immunoassays raised against alpha-melanocyte-stimulating hormone can cross-react, so chromatographic confirmation is normally required. Urinary detection windows are short, and reported limits of detection differ substantially between laboratories.
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Unapproved in the US, EU and Australia | Sale and import restricted; no licensed product |
| Typical test matrices | Urine, serum, seized powder | Urinary detection window is short |
| Primary identification method | LC-MS/MS against a reference standard | High-resolution mass used for confirmation |
| Data sources in the literature | Small trials, case reports, pharmacovigilance | No registrational trial dataset exists |
| Common marketing names | Melanotan 2, MT-II, MT-2 | Label content may not match declared peptide |
Published research on the compound remains limited. Much of the human data comes from small, early-stage studies rather than large controlled trials, and several questions about effects and variability between individuals remain open. Investigators have examined receptor activity, pigment pathways, and related physiological responses in laboratory and animal models. Findings from those models do not automatically translate to human outcomes. Reviews frequently note the scarcity of rigorous clinical evidence and call for better-characterized study material.
Because the substance circulates mainly through informal markets, verification is a recurring theme in technical discussion. Independent analyses have found that labeled content and actual content can diverge, and that purity varies between samples. Analytical laboratories use reversed-phase chromatography to separate components and mass spectrometry to confirm identity. Isotope-labeled internal standards improve quantification in complex matrices. Such methods describe what a sample contains but say nothing about its sterility, lawful status, or suitability for any use. Open questions remain about how consistently testing is applied across the supply chain.
No regulatory authority has approved melanotan-2 for human use, and several countries classify it as a prescription-only or controlled substance, which restricts lawful supply. Material sold online is generally labelled as a research chemical and is not required to meet pharmaceutical standards of identity or purity. Published human data consist mainly of small uncontrolled studies, case reports and adverse-event notifications, so the evidence base is descriptive rather than confirmatory. Whether repeated melanocyte stimulation alters long-term naevus behaviour remains an open question that no completed trial has resolved.
Melanotan-2 is a synthetic cyclic heptapeptide designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous tridecapeptide that regulates pigment production. Two modifications distinguish it from the natural hormone: norleucine replaces methionine at the N-terminus, which limits oxidation, and a D-phenylalanine substitution raises receptor affinity. The ring is closed through an aspartate-lysine lactam bridge, giving the molecule a constrained conformation. The free base has a molecular mass near 1024 daltons, and commercial material is usually supplied as an acetate salt. It appears in the literature as a research peptide rather than an approved therapeutic agent.
Receptor studies place melanotan-2 among non-selective melanocortin agonists, binding MC1R, MC3R, MC4R and MC5R rather than a single subtype. Activation of MC1R on cutaneous melanocytes raises tyrosinase activity and shifts pigment synthesis toward eumelanin, which is darker and more photostable than pheomelanin. Central receptors, particularly MC4R, are associated with appetite suppression and with reported effects on sexual function. Because subtype selectivity is low, the same molecule engages pigment, metabolic and vascular pathways at once, and this breadth is a common explanation offered for the range of adverse events described in user reports.
2GO Group, Inc. (branded as 2GO) is a Philippine logistics and transportation company engaged in freight shipping, courier and parcel delivery, warehousing, inventory management, distribution, and passenger sea travel. It operates a fleet of ten inter-island vessels transporting cargo and passengers across domestic routes in the Philippines. The company traces its roots to William Lines, Inc., which was established on May 26, 1949. William Lines grew to become one of the largest shipping companies in the Philippines during the 1970s to the 1990s, before eventually merging with other domestic shipping firms that later formed what is now known as 2GO Group, Inc. 2GO is a subsidiary of SM Investments Corporation (SMIC), one of the country's largest conglomerates. Another principal shareholder is Trident Investments.
=== September === September 8, 2008: Latvia Latvia joins its northern neighbor Estonia in recession as GDP falls 0.2% in the second quarter from the first quarter, when it fell 0.3%. Property markets and construction have suffered in both Baltic states.
== Acquisitions == In 1988, Charles River purchased Specific Pathogen Antigen Free Avian Services (SPAFAS) and serologic diagnostic services Merck, Sharp, and Dohme. Between 1996 and 2000, the company acquired Endosafe, Inc. and Sierra Biomedical. In October 2003, Charles River Laboratories merged with Inveresk, a research company based in the United Kingdom. The company was known then as Charles River Laboratories. Inveresk specialised in clinical research and pre-clinical testing, and their main facilities are in Edinburgh, Scotland. In late 2009, Charles River sold its Clinical Services Division in Edinburgh to Quotient Bioresearch. In 2010, Charles River Laboratories attempted to acquire WuXi PharmaTech, a China-based contract research organization, but the offer was withdrawn when the deal faced opposition from several large Charles River investors, including Relational Investors, JANA Partners, and Neuberger Berman. The proxy advisory firm RiskMetrics had also recommended that Charles River's shareholders vote against the proposed deal. From 2008 to 2013, Charles River acquires several companies including NewLab Bioquality AG, MIR Preclinical Services, Piedmont Research Center, LLC, Cerebricon, Ltd., Accugenix, and Vital River, allowing the company to expand their research models and services portfolio to drug development and discovery markets in China.
Sources: en.wikipedia.org
=== External phylogeny === Animals are monophyletic, meaning they are derived from a common ancestor. Animals are the sister group to the choanoflagellates, with which they form the Choanozoa. Ros-Rocher and colleagues (2021) trace the origins of animals to unicellular ancestors, providing the external phylogeny shown in the cladogram. Uncertainty of relationships is indicated with dashed lines. The animal clade had certainly originated by 650 mya, and may have come into being as much as 800 mya, based on molecular clock evidence for different phyla.
=== India === India has been developing fast breeder reactors as part of its three-stage nuclear power programme. India's Prototype Fast Breeder Reactor at Kalpakkam reached first criticality on 6 April 2026. Its uranium–plutonium fuel cycle is separate from the programme's longer-term thorium plans. BHAVINI, an Indian nuclear power company, was established in 2003 to construct, commission, and operate all stage II fast breeder reactors outlined in India's three-stage nuclear power programme. To advance these plans, the FBR-600 is a pool-type sodium-cooled reactor with a rating of 600 MWe.
==== Umeko ==== Koume Kodou (胡堂 小梅, Kodō Koume), also known as "Umeko" (ウメコ), is a ditzy, yet kind-hearted and perky, member of the team who serves as Deka Pink (デカピンク, Deka Pinku), though she frequently claims to be the field leader. Throughout the series, she spends every moment she can in a bubble bath with her three rubber ducks, Umeyo, Umenosuke, and Umegoro. After learning of Sen-chan's feelings for her, she moves in with him, as of the crossover film Mahō Sentai Magiranger vs. Dekaranger. As Deka Pink, Umeko wields the D-Knuckle and D-Stick, which can combine to form the D-Shot and allow her to perform the Twin Cam Shot alongside Jasmine. Using the SP License's Masquerade Mode (マスカレイドモード, Masukareido Mōdo), she can instantaneously change her outfit for disguise purposes. Umeko is portrayed by Mika Kikuchi (菊地 美香, Kikuchi Mika).
McKenna found Ari and Chloe's reunion to be "very emotional" and thought it was obvious that they have "a good relationship". She called Ari "a pretty decent guy" and "smooth" for telling Mac about Chloe and Mia. McKenna thought Mac and Ari's break-up was sad, but also obvious to everyone, writing "We all saw the breakup coming but after everything Mac has done for the Parata's — she even gave them her Porsche as drug collateral — it cuts real deep and it's another heartbreak for Home and Away." She later admonished Ari for his actions, writing "Oh Ari, we expected so much better from you. Ari literally left Mac and moved his old girlfriend in immediately and he's somehow surprised that she can't handle the sight of him?" Digital Spy's Susannah Alexander and Daniel Kilkelly believed the serial "lost a solid couple" in Ari and Mac and that fans of the pair were "upset to see them go their separate ways." After Ari and Mia learned they were expecting a baby, Stephen Downie of TV Week stated "If any couple deserves some happiness, it's Ari and Mia". McKenna later labelled Ari's final storyline "heart wrenching" and his wedding to Mia "bittersweet". Entertainment Daily's Steven Murphy said Ari's death "left viewers distraught" and was "a real shock" to those who had no idea Kipa-Williams was leaving the show. He also wrote "The demise was certainly dramatic. But it left many viewers wondering why Home and Away had killed off one of its most popular characters."
Sources: en.wikipedia.org
A brief or only mildly elevated heart rate (heart rate taken while sitting down after recently walking across the room or getting up on the examination table) might be assumed to be due to anxiety or illness rather than exercise-induced inappropriate rapid heart rate due to an ATP shortage in the muscle cells. In the absence of severe symptoms (such as hepatomegaly, cardiomyopathy, hypoglycemia, lactic acidosis, myoglobinuria, rhabdomyolysis, acute compartment syndrome or renal failure), it is understandable that a disease would not be noticed by medical professionals for years, when at rest the patient appears completely normal. Depending on what enzyme is affected, a high-protein or low-fat diet may be recommended along with mild exercise. It is important for people with metabolic myopathies to consult with their doctors for a treatment plan in order to prevent acute muscle breakdowns while exercising that lead to the release of muscle proteins into the bloodstream that can cause kidney damage. A ketogenic diet has a remarkable effect on CNS-symptoms in PDH-deficiency and has also been tried in complex I deficiency. A ketogenic diet has demonstrated beneficial for McArdle disease (GSD-V) as ketones readily convert to acetyl CoA for oxidative phosphorylation, whereas free fatty acids take a few minutes to convert into acetyl CoA. As of 2022, another study on a ketogenic diet and McArdle disease (GSD-V) is underway.
The amendments required union leaders to file affidavits with the United States Department of Labor declaring that they were not supporters of the Communist Party and had no relationship with any organization seeking the "overthrow of the United States government by force or by any illegal or unconstitutional means" as a condition to participating in NLRB proceedings. Just over a year after Taft–Hartley passed, 81,000 union officers from nearly 120 unions had filed the required affidavits. This provision was at first upheld in the 1950 Supreme Court decision American Communications Ass'n v. Douds, but in 1965 in United States v. Brown, the Supreme Court held that this provision was an unconstitutional bill of attainder.
=== Additional instar === Two populations of C. brunneus have females that have an additional instar inserted between instar II and III termed instar IIa. Morphological characteristics of instar IIa are a mixture of instars II and III. Females are of an intermediate size and length between instars II and III. Wing buds closely resemble the wing buds of instar II but have more venation than the typical wing buds of instar II. Genitalia development is closer to the development of instar III development. Additional instars have been found in other acridid species that display sexual dimorphism in which females are larger than males such as C. parallelus. C. brunneus females on average are 3 to 4 times larger than males. The occurrence of the additional instar most likely reflects the habitat the C. brunneus females occur. Females with the additional instar have only been found to occur in the region of East Anglia in Britain. The longer summers in East Anglia may facilitate earlier hatching and an increased growth rate permitting the inclusion of instar IIa allowing the females to reach a larger size. Decreased availability of food may encourage rapid development also explaining the inclusion of an additional instar.
== Notes == "EMDB-1067: Ribosomal 80S-eEF2-sordarin complex from S. cerevisiae - EM Navigator". emnavi.protein.osaka-u.ac.jp. Retrieved 2009-08-06.{{cite web}}: CS1 maint: deprecated archival service (link) Giavalisco P, Wilson D, Kreitler T, et al. (March 2005). "High heterogeneity within the ribosomal proteins of the Arabidopsis thaliana 80S ribosome". Plant Mol. Biol. 57 (4): 577–591. Bibcode:2005PMolB..57..577G. doi:10.1007/s11103-005-0699-3. hdl:11858/00-001M-0000-0010-86C6-1. PMID 15821981. S2CID 14500573. "Ribosomes". www.cs.stedwards.edu. Archived from the original on 2009-03-20. Retrieved 2009-08-06.
Cold Mountain is an American opera in two acts and an epilogue, with music by Jennifer Higdon and the libretto by Gene Scheer, based on Charles Frazier's 1997 novel of the same name. The opera is a co-commission among Santa Fe Opera, Opera Philadelphia and the Minnesota Opera, in collaboration with North Carolina Opera. The opera received its world premiere at Santa Fe Opera on 1 August 2015. This production coincided with the 150th anniversary of the ending of the American Civil War. Opera Philadelphia gave its first performance of the opera, in a slightly revised form, on 5 February 2016. North Carolina Opera gave the opera its home state premiere on 28 September 2017. The Minnesota Opera staged the opera in 2018 as part of its New Works Initiative. The Virginia Opera also featured performances of the opera during February 2021 as part of its themed "Love is a Battlefield" 2020–2021 season.
Sources: en.wikipedia.org
Regulatory treatment varies by country. In the United States, the European Union and Australia it is an unapproved drug and its sale is restricted, while some other jurisdictions list it as prescription-only or controlled. The applicable rules depend on the country of import.
Reversed-phase LC-MS/MS is the usual approach for both identification and quantitation. High-resolution mass spectrometry and peptide mapping serve as confirmatory methods. Immunoassays are rarely used alone because of cross-reactivity.
Published testing of seized and purchased samples frequently reports discrepancies between declared and measured peptide content. Counter-ion content and residual solvents add further variation. Independent analysis is the only way to confirm composition.
It is a synthetic seven-amino-acid peptide modeled on alpha-melanocyte-stimulating hormone. It carries two non-natural substitutions and a cyclic bridge that increase its stability relative to the natural hormone. It circulates as a research chemical and is not an approved medicine.